Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 37

Sort by

Sort Order Select

Journal Articles

Recipient Signaling through the Cannabinoid Type 2 Receptor Regulates IL-6 Independent Neuroinflammation during Graft Versus Host Disease

Alison Moe, PhD, Garrett Sauber, BS, Vivian Zhou, PhD, Anissa Lapitz, BS, Cecilia Hillard, PhD, William R. Drobyski, MD

Blood (2019) 134 (Supplement_1): 195.

https://doi.org/10.1182/blood-2019-122746

Published: 2019

Journal Articles

A Clinical Trial of Cannabis As Targeted Therapy for Indolent Leukemic Lymphoma

Christopher M Melén, MD, Magali Merrien, MSc, Agata Wasik, MSc, PhD, Kristina Sonnevi, MD PhD, Henna-Riikka Junlén, MD, Birger Christersson, MD PhD, Birgitta Sander, MD PhD Prof., Björn E Wahlin, MD PhD

Blood (2019) 134 (Supplement_1): 5487.

https://doi.org/10.1182/blood-2019-126693

Published: 2019

Journal Articles

A Case Report of the Benefit of Cannabidiol (Cannabidiol (CBD)-Predominant Medical Cannabis Preparation) in the Management of Refractory Skin Graft Vs Host Disease (GVHD)

Tsiporah B. Shore, MD, Jessy B. Ryan, ANP, Michael B. Samuel, MD

Blood (2019) 134 (Supplement_1): 5687.

https://doi.org/10.1182/blood-2019-122715

Published: 2019

Journal Articles

Characteristics of Marijuana Usage in Sickle Cell Patients: A Nationwide Analysis

Arya Mariam Roy, MD, Manojna Konda, MD, Akshay Goel, MD, Appalanaidu Sasapu, MD

Blood (2019) 134 (Supplement_1): 4848.

https://doi.org/10.1182/blood-2019-131489

Published: 2019

Journal Articles

Synergistic Effect of Cannabidiol with Conventional Chemotherapy Treatment

Tori Strong, PhD, Jana Rauvolfova, PhD, Elias Jackson, PhD, Lan V. Pham, PhD, Jerry Bryant

Blood (2018) 132 (Supplement 1): 5382.

https://doi.org/10.1182/blood-2018-99-116749

Published: 2018

Journal Articles

Medical Marijuana for Sickle Cell Disease: Results of Two Years of Certification in an Adult Sickle Cell Center

Susanna A Curtis, MD, Dana Lew, BS, Jonathan Spodick, MA, LCSW, John D. Roberts, MD

Blood (2018) 132 (Supplement 1): 858.

https://doi.org/10.1182/blood-2018-99-118290

Published: 2018

Journal Articles

Daily Users of Marijuana with Sickle Cell Disease Report More Severe Pain Crisis Yet Have Similar Rates of Admission to Non-Users

Susanna A Curtis, MD, Michelle Deveaux, Daniel Zelterman, Lesley Devine, PhD, Amanda M Brandow, DO, MS, John D. Roberts, MD

Blood (2017) 130 (Supplement 1): 3559.

https://doi.org/10.1182/blood.V130.Suppl_1.3559.3559

Published: 2017

Journal Articles

Cannabinoid Receptor Signaling As a Target for Personalized Therapy in Aggressive B Cell Lymphomas

Lan Pham, PhD, Juan Chen, PhD, Archie Tamayo, MS, Jerry Bryant, David Yang, PhD, Richard J. Ford, Jr., MD PhD

Blood (2016) 128 (22): 4181.

https://doi.org/10.1182/blood.V128.22.4181.4181

Published: 2016

Journal Articles

Use of Marijuana in Patients with Sickle Cell Disease Increased the Frequency of Hospitalization for Acute Painful Vaso-Occlusive Crises

Samir K. Ballas, MD

Blood (2016) 128 (22): 2498.

https://doi.org/10.1182/blood.V128.22.2498.2498

Published: 2016

Journal Articles

Cannabinoids Derivatives Exert a Potent Antileukemic Effect By Modifying the Pattern of Membrane Sphingolipids

Mayte Medrano, María Victoria Barbado-Gonzalez, Nuria Campillo, Francisco Hidalgo, Teresa Caballero-Velazquez, Olga Perez-Lopez, Maria Sole-Rodriguez, Jose Ignacio Piruat-Palomo, Jose A. Perez-Simon, MD, PhD

Blood (2016) 128 (22): 4718.

https://doi.org/10.1182/blood.V128.22.4718.4718

Published: 2016

Journal Articles

Efficacy of Lidocaine Patch in Relieving Severe Sickle Cell Leg Ulcer Pain

Clarisse Lopes de Castro Lobo, ASH, MEMBER, Ana Maria Mach Queiroz, MD, Agueda Gloria Sabino De Matos, Eleonora D'Avila Thome, Samir K. Ballas, MD

Blood (2015) 126 (23): 4596.

https://doi.org/10.1182/blood.V126.23.4596.4596

Published: 2015

Journal Articles

Hemin-Induced Mast Cell-Extracellular Traps Impart Resistance to Therapy in a Sickle Microenvironment

Huy Tran, BS, Ritu Jha, M.sc, Julia Nguyen, BS, Sarita Jarrett, High School, Jonathan Rodriguez, Undergraduate, Aditya Mittal, High School, Jianxun Lei, PhD, Kalpna Gupta, PhD

Blood (2015) 126 (23): 3385.

https://doi.org/10.1182/blood.V126.23.3385.3385

Published: 2015

Journal Articles

Cannabinoids As Antimyeloma Agents: a New Approach for the Treatment of Multiple Myeloma

María Victoria Barbado, PhD, Mayte Medrano, Jose Ignacio Piruat, PhD, Ivan Valle, Teresa Caballero, PhD, Isabel Álvarez, Jose Antonio Perez-Simón, MDPhD

Blood (2014) 124 (21): 4724.

https://doi.org/10.1182/blood.V124.21.4724.4724

Published: 2014

Journal Articles

The Endocannabinoid/Endovanilloid N-Arachidonoyl Dopamine Suppresses the Plasma Membrane Translocation and Neoplastic Transforming Activity of NRAS and KRAS4A

Min Wu, PhDcandidate, Bo Jiao, PhD, Ruibao Ren, MD/PhD

Blood (2014) 124 (21): 434.

https://doi.org/10.1182/blood.V124.21.434.434

Published: 2014

Journal Articles

Cannabinoid Receptor 1 in Chronic Lymphocytic Leukemia: Strong Prognostic Marker with Limited Therapeutic Use

Patricia Weiss, Edit Anna Porpaczy, MD, Trang Le, Cathrin Skrabs, Michaela Gruber, Clemens Pausz, Ulrich Jäger, Katrina Vanura

Blood (2012) 120 (21): 4565.

https://doi.org/10.1182/blood.V120.21.4565.4565

Published: 2012

Journal Articles

TRPV2 Expression and Its Role in Proliferation of Human Multiple Myeloma Cell Lines

Massimo Nabissi, Massimo Offidani, Maria Beatrice Morelli, Manila Pettinari, Patrizia Caraffa, Silvia Gentili, Laura Corvatta, Giorgio Santoni, Francesco Alesiani, Pietro Leoni, MD

Blood (2011) 118 (21): 5003.

https://doi.org/10.1182/blood.V118.21.5003.5003

Published: 2011

Journal Articles

Genetic and pharmacologic inactivation of cannabinoid CB1 receptor inhibits angiogenesis

Simona Pisanti, Paola Picardi, Lucia Prota, Maria Chiara Proto, Chiara Laezza, Paul G. McGuire, Lucia Morbidelli, Patrizia Gazzerro, Marina Ziche, Arup Das, Maurizio Bifulco

Blood (2011) 117 (20): 5541–5550.

https://doi.org/10.1182/blood-2010-09-307355

Published: 2011

Journal Articles

Cannabinoid receptor 2 and its agonists mediate hematopoiesis and hematopoietic stem and progenitor cell mobilization

Shuxian Jiang, Meritxell Alberich-Jorda, Radoslaw Zagozdzon, Kalindi Parmar, Yigong Fu, Peter Mauch, Naheed Banu, Alexandros Makriyannis, Daniel G. Tenen, Shalom Avraham, Jerome E. Groopman, Hava Karsenty Avraham

Blood (2011) 117 (3): 827–838.

https://doi.org/10.1182/blood-2010-01-265082

Published: 2011

Includes: Supplemental data

Journal Articles

Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids

Divyanshoo R. Kohli, Yunfang Li, Sergey G. Khasabov, Pankaj Gupta, Lois J. Kehl, Marna E. Ericson, Julia Nguyen, Vinita Gupta, Robert P. Hebbel, Donald A. Simone, Kalpna Gupta

Blood (2010) 116 (3): 456–465.

https://doi.org/10.1182/blood-2010-01-260372

Published: 2010

Includes: Supplemental data

Journal Articles

Cannabinoids as Analgesics for Pain in Sickle Cell Disease.

Divyanshoo Rai Kohli, Yunfang Li, MD, Sergey G Khasabov, Marna E Ericson, Pankaj Gupta, MD, Donald A Simone, Robert P Hebbel, MD, Kalpna Gupta, PhD

Blood (2009) 114 (22): 822.

https://doi.org/10.1182/blood.V114.22.822.822

Published: 2009

NARROW

Recipient Signaling through the Cannabinoid Type 2 Receptor Regulates IL-6 Independent Neuroinflammation during Graft Versus Host Disease

A Clinical Trial of Cannabis As Targeted Therapy for Indolent Leukemic Lymphoma

A Case Report of the Benefit of Cannabidiol (Cannabidiol (CBD)-Predominant Medical Cannabis Preparation) in the Management of Refractory Skin Graft Vs Host Disease (GVHD)

Characteristics of Marijuana Usage in Sickle Cell Patients: A Nationwide Analysis

Synergistic Effect of Cannabidiol with Conventional Chemotherapy Treatment

Medical Marijuana for Sickle Cell Disease: Results of Two Years of Certification in an Adult Sickle Cell Center

Daily Users of Marijuana with Sickle Cell Disease Report More Severe Pain Crisis Yet Have Similar Rates of Admission to Non-Users

Cannabinoid Receptor Signaling As a Target for Personalized Therapy in Aggressive B Cell Lymphomas

Use of Marijuana in Patients with Sickle Cell Disease Increased the Frequency of Hospitalization for Acute Painful Vaso-Occlusive Crises

Cannabinoids Derivatives Exert a Potent Antileukemic Effect By Modifying the Pattern of Membrane Sphingolipids

Efficacy of Lidocaine Patch in Relieving Severe Sickle Cell Leg Ulcer Pain

Hemin-Induced Mast Cell-Extracellular Traps Impart Resistance to Therapy in a Sickle Microenvironment

Cannabinoids As Antimyeloma Agents: a New Approach for the Treatment of Multiple Myeloma

The Endocannabinoid/Endovanilloid N-Arachidonoyl Dopamine Suppresses the Plasma Membrane Translocation and Neoplastic Transforming Activity of NRAS and KRAS4A

Cannabinoid Receptor 1 in Chronic Lymphocytic Leukemia: Strong Prognostic Marker with Limited Therapeutic Use

TRPV2 Expression and Its Role in Proliferation of Human Multiple Myeloma Cell Lines

Genetic and pharmacologic inactivation of cannabinoid CB1 receptor inhibits angiogenesis

Cannabinoid receptor 2 and its agonists mediate hematopoiesis and hematopoietic stem and progenitor cell mobilization

Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids

Cannabinoids as Analgesics for Pain in Sickle Cell Disease.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only